Healthcare · Biotechnology
Price
$1.24
Market Cap
$132.8M
Employees
91
Beta
1.67
Avg Volume
954,654
CEO
Maher Masoud
Business Description
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Business History
Price Overview
Last updated: Jun 27, 2026 10:04am (just now)$1.24
-0.03 (-2.36%)
Day Range
$1.23 – $1.36
52-Week Range
$0.64 – $2.37
50-Day MA
$1.03
200-Day MA
$1.21
Volume
14,015,309.00
Analyst Price Targets
Low
$6.00
Consensus
$6.00
High
$6.00
(3 analysts)
Share Structure
Outstanding
107,121,672.00
Float
97,667,113.00
Free Float
91.2%
High free float
— 91.2% of shares trade freely, ~8.8% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-2.95
Stock Price: $1.24
EPS (Diluted): -0.42
EPS (Diluted): -0.42
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.96
Stock Price: $1.24
Total Equity: $171.49M
Shares: 106,427,854
Total Equity: $171.49M
Shares: 106,427,854
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-3.92
Market Cap: $132.83M
Total Debt: $1.46M
Cash: $20.07M
EBITDA: -$39.49M
Total Debt: $1.46M
Cash: $20.07M
EBITDA: -$39.49M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$162.8M
Market Cap: $132.83M
Total Debt: $1.46M
Cash: $20.07M
Total Debt: $1.46M
Cash: $20.07M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
4.99
Stock Price: $1.24
Revenue: $33.03M
Shares: 106,427,854
Revenue: $33.03M
Shares: 106,427,854
EV/Sales (Total value vs revenue — works when P/E can't)
API4.93
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
81.2%
Gross Profit: $26.80M
Revenue: $33.03M
Revenue: $33.03M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-137.1%
Operating Income: -$45.29M
Revenue: $33.03M
Revenue: $33.03M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-135.1%
Net Income: -$44.63M
Revenue: $33.03M
Revenue: $33.03M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-22.0%
Net Income: -$44.63M
Total Equity: $171.49M
Total Equity: $171.49M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-20.8%
Operating Income: -$45.29M
Tax Rate: 0.0%
Equity: $171.49M
Total Debt: $1.46M
Cash: $20.07M
Tax Rate: 0.0%
Equity: $171.49M
Total Debt: $1.46M
Cash: $20.07M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
8.30
Current Assets: $118.37M
Current Liabilities: $14.27M
Current Liabilities: $14.27M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.01
Short-Term Debt: $1.46M
Long-Term Debt: $0.00
Total Debt: $1.46M
Total Equity: $171.49M
Long-Term Debt: $0.00
Total Debt: $1.46M
Total Equity: $171.49M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.31
Revenue: $33.03M
Shares: 106,427,854
Shares: 106,427,854
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$1.61
Total Equity: $171.49M
Shares: 106,427,854
Shares: 106,427,854
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.34
Operating CF: -$34.41M
CapEx: -$1.77M
Shares: 106,427,854
CapEx: -$1.77M
Shares: 106,427,854
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $1.24
Stock Price: $1.24
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$44.63M
Net Income: -$44.63M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares MXCT against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 23, 2026 5:10pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $33.9M | $44.3M | $41.3M | $38.6M | $33.0M |
| Cost of Revenue | $3.6M | $5.1M | $4.7M | $7.1M | $6.2M |
| Gross Profit | $30.2M | $39.2M | $36.5M | $31.5M | $26.8M |
| Operating Expenses | $48.4M | $66.5M | $84.8M | $82.7M | $72.1M |
| Operating Income | -$18.2M | -$27.4M | -$48.3M | -$51.2M | -$45.3M |
| Net Income | -$19.1M | -$23.6M | -$37.9M | -$41.1M | -$44.6M |
| EBITDA | -$16.6M | -$20.7M | -$33.8M | -$36.3M | -$39.5M |
| EPS | $-0.22 | $-0.19 | $-0.37 | $-0.39 | $-0.42 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 5:10pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $47.8M | $11.1M | $46.5M | $27.9M | $20.1M |
| Total Current Assets | $270.4M | $252.3M | $190.2M | $171.7M | $118.4M |
| Total Assets | $284.1M | $286.7M | $268.3M | $239.5M | $202.5M |
| Current Liabilities | $15.6M | $15.4M | $17.9M | $15.8M | $14.3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $21.2M | $32.7M | $36.1M | $33.2M | $31.0M |
| Total Equity | $262.9M | $254.0M | $232.2M | $206.3M | $171.5M |
| Retained Earnings | -$114.3M | -$137.9M | -$175.8M | -$216.9M | -$261.5M |
Cash Flow (Annual)
Last updated: Jun 23, 2026 5:10pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$10.7M | -$14.8M | -$21.7M | -$27.6M | -$34.4M |
| Capital Expenditure | -$3.8M | -$18.5M | -$3.7M | -$1.7M | -$1.8M |
| Free Cash Flow | -$14.5M | -$33.3M | -$25.4M | -$29.3M | -$36.2M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | -$1.8M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $29.0M | -$36.7M | $35.4M | -$18.6M | -$7.8M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 10:04am (just now)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$31.1M $31.0M – $31.1M
|
$37.6M $34.8M – $40.3M
|
$44.6M $44.1M – $45.1M
|
$81.5M $77.9M – $85.3M
|
| EBITDA |
-$23.1M -$23.1M – -$23.1M
|
-$27.9M -$30.0M – -$25.9M
|
-$33.1M -$33.5M – -$32.8M
|
-$60.6M -$63.4M – -$57.9M
|
| Net Income |
-$27.9M -$28.3M – -$27.6M
|
-$28.2M -$30.7M – -$24.3M
|
-$21.3M -$22.6M – -$20.1M
|
-$11.7M -$12.4M – -$11.0M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 5:10pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +30.6% | -6.7% | -6.4% | -14.5% |
| Gross Profit Growth | +29.5% | -6.7% | -13.7% | -15.0% |
| Operating Income Growth | -50.4% | -76.5% | -6.0% | +11.5% |
| Net Income Growth | -23.5% | -60.9% | -8.3% | -8.7% |
| EBITDA Growth | -24.9% | -62.7% | -7.4% | -8.9% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Johnston John Joseph | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | Johnston John Joseph | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | Hemrajani Rekha | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | Hemrajani Rekha | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | Erck Stanley C | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | Erck Stanley C | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | DOUGLAS RICHARD | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | DOUGLAS RICHARD | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | Collins Cynthia | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | Collins Cynthia | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | Brooke William W | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | Brooke William W | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | BALTHROP PATRICK J | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | BALTHROP PATRICK J | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-06-17 | Al-Wakeel Yasir B. | A-Award | 30,421.00 | $0.00 | $0 |
| 2026-06-17 | Al-Wakeel Yasir B. | A-Award | 49,579.00 | $1.13 | $56,024 |
| 2026-04-15 | Ahuja Parmeet | A-Award | 187,500.00 | $0.00 | $0 |
| 2026-03-30 | Ahuja Parmeet | A-Award | 375,000.00 | $0.68 | $253,575 |
| 2026-03-30 | Ahuja Parmeet | 0.00 | $0.00 | $0 | |
| 2026-03-27 | Masoud Maher | A-Award | 600,000.00 | $0.68 | $410,400 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for MXCT — it's generated by the pipeline (
market-narrative step).
No community reviews yet for MXCT.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30